| P2093 | author name string | Caren G. Solomon | |
| | Eugene D. Shapiro | |
| P2860 | cites work | Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q22241656 |
| | Diagnosis of lyme borreliosis | Q22242237 |
| | Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay | Q22242917 |
| | The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America | Q22242935 |
| | Prospective study of serologic tests for lyme disease | Q22242954 |
| | Prospective Clinical Evaluation of Patients from Missouri and New York with Erythema Migrans--Like Skin Lesions | Q22242959 |
| | A Critical Appraisal of “Chronic Lyme Disease” | Q22248114 |
| | Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease | Q22250903 |
| | Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans | Q28207826 |
| | Assessment and management of medically unexplained symptoms | Q28280306 |
| | Does this patient have erythema migrans? | Q28306954 |
| | Lyme borreliosis | Q29013670 |
| | Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis | Q33552032 |
| | Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease | Q33738269 |
| | Failure of treatment with cephalexin for Lyme disease | Q33906487 |
| | Inaccurate information about lyme disease on the internet | Q33984143 |
| | Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite | Q34083810 |
| | Chronic Lyme disease: in defense of the scientific enterprise | Q34126004 |
| | Chronic Lyme disease: the controversies and the science | Q34205531 |
| | Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans | Q34998560 |
| | Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. | Q36040985 |
| | Differentiation of reinfection from relapse in recurrent Lyme disease | Q36477144 |
| | Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. | Q36543739 |
| | Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease | Q36933024 |
| | Reinfection in patients with Lyme disease | Q36945744 |
| | Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease | Q37419786 |
| | Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe | Q37672965 |
| | The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans | Q40669381 |
| | Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors | Q40985089 |
| | Changing epidemiology of Powassan encephalitis in North America suggests the emergence of the deer tick virus subtype | Q42996817 |
| | Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial | Q44428323 |
| | How can we prevent Lyme disease? | Q44962600 |
| | Case-control study of risk factors for incident Lyme disease in California. | Q45944958 |
| | Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial | Q46529042 |
| | Prolonged Lyme disease treatment: enough is enough | Q46956643 |
| | Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. | Q51001453 |
| | Duration of tick bites in a Lyme disease-endemic area. | Q52312797 |
| | Borrelia miyamotoi: a lesson in disease discovery. | Q55057255 |
| | The Presenting Manifestations of Lyme Disease and the Outcomes of Treatment | Q59759433 |
| | Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease | Q63664757 |
| | Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method | Q64128520 |
| | Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks | Q64135781 |
| | Misdiagnosis of Lyme disease: when not to order serologic tests | Q71700113 |
| | Childhood neurologic disorders and Lyme disease during pregnancy | Q72871759 |
| | Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients | Q72906835 |
| | Doxycycline for tick bites--not for everyone | Q74192365 |
| | Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease | Q74396333 |
| | Brief communication: hematogenous dissemination in early Lyme disease | Q81708188 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lyme disease | Q201989 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1724-1731 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Lyme Disease | |
| P478 | volume | 370 | |